Three doses of BNT162b2 vaccine confer neutralising antibody capacity against the SARS-CoV-2 Omicron variant.

Kevin K AriënLeo HeyndrickxJohan MichielsKatleen VereeckenKurt Van LentSandra CoppensBetty WillemsPieter Pannus Geert Antoine Martens Marjan Van EsbroeckMaria E GoossensArnaud MarchantKoen BartholomeeusenIsabelle Desombere

Published in: NPJ vaccines (2022)

We report the levels of neutralising antibodies against Wuhan, Delta and Omicron variants in unimmunized infected (group 1), immunised and boosted (group 2) and infected immunised and boosted (group 3) adult individuals. Our observations support the rapid administration of a booster vaccine dose to prevent infection and disease caused by Omicron.

Keyphrases

sars cov
coronavirus disease
copy number
respiratory syndrome coronavirus
gene expression
loop mediated isothermal amplification